Tonix Pharmaceuticals Stock Forecast, Price & News

Tonix Pharmaceuticals (NASDAQ:TNXP) Frequently Asked Questions

Is Tonix Pharmaceuticals a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Tonix Pharmaceuticals in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Tonix Pharmaceuticals stock.
View analyst ratings for Tonix Pharmaceuticals or view top-rated stocks.

How has Tonix Pharmaceuticals' stock been impacted by Coronavirus?

Tonix Pharmaceuticals' stock was trading at $0.8311 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, TNXP stock has decreased by 66.6% and is now trading at $0.2780.
View which stocks have been most impacted by COVID-19.

When is Tonix Pharmaceuticals' next earnings date?

Tonix Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Monday, March 21st 2022.
View our earnings forecast for Tonix Pharmaceuticals.

How were Tonix Pharmaceuticals' earnings last quarter?

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) posted its quarterly earnings data on Sunday, November, 7th. The company reported ($0.05) earnings per share for the quarter, topping analysts' consensus estimates of ($0.07) by $0.02.
View Tonix Pharmaceuticals' earnings history.

When did Tonix Pharmaceuticals' stock split? How did Tonix Pharmaceuticals' stock split work?

Shares of Tonix Pharmaceuticals reverse split on Wednesday, November 28th 2018. The 1-10 reverse split was announced on Tuesday, November 27th 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, November 27th 2018. An investor that had 100 shares of Tonix Pharmaceuticals stock prior to the reverse split would have 10 shares after the split.

What price target have analysts set for TNXP?

1 brokers have issued 12 month target prices for Tonix Pharmaceuticals' stock. Their forecasts range from $2.00 to $2.00. On average, they expect Tonix Pharmaceuticals' share price to reach $2.00 in the next year. This suggests a possible upside of 619.4% from the stock's current price.
View analysts' price targets for Tonix Pharmaceuticals or view top-rated stocks among Wall Street analysts.

Who are Tonix Pharmaceuticals' key executives?

Tonix Pharmaceuticals' management team includes the following people:

• Seth Lederman, Chairman, President & Chief Executive Officer (LinkedIn Profile)
• Jessica Edgar Morris, Chief Operating Officer
• Bradley Saenger, Treasurer & Chief Financial Officer
• Gregory M. Sullivan, Secretary & Chief Medical Officer

Who are some of Tonix Pharmaceuticals' key competitors?

Some companies that are related to Tonix Pharmaceuticals include LianBio (LIAN), Albireo Pharma (ALBO), Fulcrum Therapeutics (FULC), Inventiva (IVA), BioXcel Therapeutics (BTAI), Relmada Therapeutics (RLMD), Lexicon Pharmaceuticals (LXRX), POINT Biopharma Global (PNT), SIGA Technologies (SIGA), Intercept Pharmaceuticals (ICPT), Chimerix (CMRX), Deciphera Pharmaceuticals (DCPH), Y-mAbs Therapeutics (YMAB), VBI Vaccines (VBIV) and Tyra Biosciences (TYRA).
View all of TNXP's competitors.

What other stocks do shareholders of Tonix Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tonix Pharmaceuticals investors own include Sorrento Therapeutics (SRNE), Vaxart (VXRT), Inovio Pharmaceuticals (INO), SCYNEXIS (SCYX), Rite Aid (RAD), Heat Biologics (HTBX), Matinas BioPharma (MTNB), Bionano Genomics (BNGO), VBI Vaccines (VBIV) and ADMA Biologics (ADMA).

What is Tonix Pharmaceuticals' stock symbol?

Tonix Pharmaceuticals trades on the NASDAQ under the ticker symbol "TNXP."

How do I buy shares of Tonix Pharmaceuticals?

Shares of TNXP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tonix Pharmaceuticals' stock price today?

One share of TNXP stock can currently be purchased for approximately $0.28.

How much money does Tonix Pharmaceuticals make?

Tonix Pharmaceuticals has a market capitalization of $137.96 million. The company earns $-50.46 million in net income (profit) each year or ($0.29) on an earnings per share basis.

How many employees does Tonix Pharmaceuticals have?

Tonix Pharmaceuticals employs 26 workers across the globe.

What is Tonix Pharmaceuticals' official website?

The official website for Tonix Pharmaceuticals is www.tonixpharma.com.

Where are Tonix Pharmaceuticals' headquarters?

Tonix Pharmaceuticals is headquartered at 509 MADISON AVENUE SUITE 1608, NEW YORK NY, 10022.

How can I contact Tonix Pharmaceuticals?

Tonix Pharmaceuticals' mailing address is 509 MADISON AVENUE SUITE 1608, NEW YORK NY, 10022. The company can be reached via phone at (212) 980-9155, via email at [email protected], or via fax at 212-923-5700.